Stay updated with breaking news from Willner Heller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AMETEK, Inc. (NYSE:AME – Get Free Report) VP Thomas M. Montgomery sold 6,891 shares of the stock in a transaction dated Thursday, March 21st. The shares were sold at an average price of $185.38, for a total transaction of $1,277,453.58. Following the completion of the sale, the vice president now owns 21,543 shares of the […]
Equities research analysts at Raymond James began coverage on shares of Humana (NYSE:HUM – Get Free Report) in a research note issued on Friday, Marketbeat reports. The brokerage set a “market perform” rating on the insurance provider’s stock. Several other research firms have also commented on HUM. Barclays assumed coverage on shares of Humana in […]
Edwards Lifesciences (NYSE:EW – Free Report) had its price target hoisted by Morgan Stanley from $95.00 to $103.00 in a research report sent to investors on Thursday, Benzinga reports. The firm currently has an overweight rating on the medical research company’s stock. Several other analysts have also commented on the stock. Royal Bank of Canada […]
Royal Bank of Canada reissued their sector perform rating on shares of General Mills (NYSE:GIS – Free Report) in a research report report published on Thursday, Benzinga reports. They currently have a $72.00 target price on the stock. A number of other research firms also recently commented on GIS. Mizuho boosted their price target on […]
Bristol-Myers Squibb (NYSE:BMY – Get Free Report) was downgraded by equities researchers at Societe Generale from a “buy” rating to a “hold” rating in a report released on Monday, Marketbeat reports. Other analysts have also issued research reports about the stock. StockNews.com upgraded shares of Bristol-Myers Squibb from a “buy” rating to a “strong-buy” rating […]